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The human polyoma viruses JCV and BKV establish
asymptomatic persistent infection in 65%–90% of
humans but can cause severe illness under immuno-
suppressive conditions. The mechanisms by which
these viruses evade immune recognition are
unknown. Here we show that a viral miRNA identical
in sequence between JCV and BKV targets the
stress-induced ligand ULBP3, which is a protein
recognized by the killer receptor NKG2D. Conse-
quently, viral miRNA-mediated ULBP3 downregula-
tion results in reduced NKG2D-mediated killing of
virus-infected cells by natural killer (NK) cells. Impor-
tantly, when the activity of the viral miRNA was
inhibited during infection, NK cells killed the infected
cells more efficiently. Because NKG2D is also ex-
pressed by various T cell subsets, we propose that
JCV and BKV use an identical miRNA that targets
ULBP3 to escape detection by both the innate and
adaptive immune systems, explaining how these
viruses remain latent without being eliminated by
the immune system.
INTRODUCTION
Polyoma viruses are small DNA viruses that are highly prevalent
in the human population. Among this family of viruses, the human
polyoma viruses BKV and JCV establish a subclinical persistent
infection in 65%–90% of all humans (Eash et al., 2006). Infection
by these two viruses is asymptomatic under normal conditions;
however, under immunosuppressive conditions, the persistent
virus infection can cause severe illnesses (Jiang et al., 2009).
JCV is known as the causative agent of progressive multifocal
leukoencephalopathy (PML), a rapidly progressive disease of
the central nervous system (CNS), which is fatal in about 90%
of all patients (Jiang et al., 2009; Eash et al., 2006). The virally
induced pathogenesis of BKV is polyomavirus-induced
nephropathy (PVN), which causes severe renal allograft dysfunc-
tion and ultimate graft loss (Nickeleit et al., 1999). Thus, it isCell Hoconceivable to assume that under normal conditions JCV and
BKV developed mechanisms, which so far remain unknown, to
enable their coexistence with their human hosts. The diseases
induced by both BKV and JCV have no efficient treatment, and
therefore the understanding of how these viruses escape detec-
tion by the immune system is essential, as it may lead to the
development of therapeutic approaches for the treatment of
the above mentioned viral diseases.
Polyoma viruses contain a small genome and are thought to
encode around six proteins only (Johnson, 2010; Eash et al.,
2006). Importantly, both JCV and BKV encode two miRNAs
that were so far demonstrated to target the viral protein T antigen
(Tag) (Sullivan et al., 2005; Seo et al., 2008). MiRNAs are noncod-
ing small RNA molecules that are found in almost all organisms
and are involved in nearly every biological process (Bartel,
2009). MiRNAs mainly bind to the 30 untranslated regions
(30UTRs) of protein-coding mRNA transcripts, and such binding
leads to inhibition of protein translation, which is often followed
bymRNA degradation (Bartel, 2009; Guo et al., 2010). In general,
the activity of miRNAs is moderate, and they operate as fine-
tuners of biological processes (Baek et al., 2008). Nevertheless,
the activity of a particular miRNA can have a dramatic effect on
the function of a certain protein. Furthermore, because each
miRNA can target around 300 genes, the manipulation of
miRNAs activity may also lead to dramatic and global changes
in the function of many proteins (Baek et al., 2008).
MiRNAs are also involved in immune regulation (O’Connell
et al., 2010). We have previously shown that three different viral
miRNAs, encoded by three different herpesviruses (EBV, KSHV,
and HCMV), can selectively target the stress-induced ligand
MICB and not other stress-induced ligands such as ULBPs
or MICA (Stern-Ginossar et al., 2007; Nachmani et al., 2009).
MICB is recognized by the powerful killer receptor NKG2D,
which is expressed by NK cells and by other immune cells
(Raulet, 2003). Thus, the downregulation of MICB by the viral
miRNAs results in the escape of the infected cells from the
NKG2D-mediated immune recognition and elimination (Nach-
mani et al., 2009; Stern-Ginossar et al., 2007). Since both human
polyomaviruses and herpesviruses coexist with the human host
(Speck and Ganem, 2010; Boothpur and Brennan, 2010; Eash
et al., 2006), because they can cause severe illnesses under
immunosuppressive conditions and because BKV and JCV
encode miRNAs, we hypothesized that the BKV and the JCVst & Microbe 9, 93–102, February 17, 2011 ª2011 Elsevier Inc. 93
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Figure 1. Specific Downregulation of
ULBP3 in Cells Overexpressing the BKV
and JCV miRNAs
(A) Schematic representation of the 3p* and the 5p
arms-derived miRNAs of JCV and BKV. (B and E)
Percentages (indicated in the figure) of GFP-posi-
tive BJAB cells (B) and RKO (E) cells transduced
with the indicated miRNAs. MiR-J1-3p is the
BKV-miR-B1-3p/JCV-miR-J1-3p, and the control
miR-J1-5p is the miRNA derived from the parallel
5p arm of the pre-miRNA of JCV. (C and F) FACS
analysis for the expression of all detectable
NKG2D ligands by BJAB cells (C) and by RKO cells
(F), following transduction either with the BKV-
miR-B1-3p/JCV-miR-J1-3p (miR-J1-3p, black
open histogram) or the control miR-J1-5p (gray
open histogram). The filled gray histogram repre-
sents the staining of the second mAb only. Fig-
ure shows one representative experiment out of
three performed. (D and G) Quantification of the
ULBP3 downregulation, in BJAB (D) and in RKO
(G) cells. The percentages of ULBP3 downregula-
tion (% MFI), in cells transduced with miR-J1-3p,
were calculated relative to cells transduced with
the control miR. Shown are mean values ± SD.
Statistically significant differences are indicated
(*p < 0.005, by one-tailed t test). Error bars (SD)
are derived from the result of three independent
experiments.
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Polyomaviruses miRNA Target ULBP3miRNAs may also target the NKG2D ligands to escape the
NKG2D-mediated elimination.
Here we describe an immune evasion mechanism of the
human polyoma viruses and demonstrate that through
the specific downregulation of ULBP3, a ligand for NKG2D,
BKV, and JCV escape immune cell attack. These findings
may explain how these viruses remain latent in most of the
human population without being eliminated by the immune
system.
RESULTS
The 3p* miRNAs of BKV and of JCV Specifically
Downregulate ULBP3 Expression
Whether human polyoma viruses developed mechanisms to
escape immune recognition is still unknown. Since we have
demonstrated that three different herpes viruses, HCMV,
EBV, and KSHV, all escape NKG2D-mediated recognition
through the usage of distinctive miRNAs that target MICB
(Nachmani et al., 2009; Stern-Ginossar et al., 2007), we specu-
lated that the miRNAs of BKV and JCV might also target the
stress ligands of NKG2D. To test this hypothesis and to avoid
the usage of computer algorithms which are currently still
inaccurate, we undertook a practical unbiased approach in
which we transduced BJAB cells that endogenously express
numerous NKG2D ligands with lentiviral vectors expressing
the miRNAs of JCV and BKV. We used lentiviral vectors
expressing the less abundant miRNA (3p* [Seo et al., 2008])
derived from the 3p arm of the pre-miRNAs of JCV and of94 Cell Host & Microbe 9, 93–102, February 17, 2011 ª2011 ElsevierBKV (BKV-miR-B1-3p/JCV-miR-J1-3p), which is identical
between these two viruses (we therefore designated it miR-
J1-3p, Figure 1A and throughout the manuscript). In addition
we also generated two additional lentiviral vectors containing
the 5p-derived miRNAs of BKV and JCV, which are different
between the viruses (Figure 1A). All of the lentiviral vectors
also contain a GFP cassette that enables us to monitor for
the transduction efficiency, which was in general very high (Fig-
ure 1B and all other transductions throughout the manuscript).
As can be seen in Figures 1C and 1D, a substantial decrease
(around 40%, Figure 1D) in the expression of ULBP3 was
observed in BJAB cells overexpressing miR-J1-3p, while the
other miRNAs, derived from the 5p arm of JCV, or BKV,
(miR-J1-5p and miR-B1-5p respectively), had no effect (Figures
1C and 1D and data not shown). Furthermore, other control
viral miRNAs such as ebv-BART1 or kshv-miR-K12-3 had no
effect on the ULBP3 downregulation (data not shown). There-
fore, to use a biologically relevant control, miR-J1-5p was
used as a negative control miRNA in all of the following figures.
The reduction in ULBP3 expression was specific, as no change
in the levels of all other NKG2D ligands, MICA, MICB, ULBP1,
and ULBP2, which are present on cell surface of BJAB cells,
was observed (Figure 1C). To further corroborate these obser-
vations, we transduced another cell line, RKO, which endoge-
nously expresses ULBP3, ULBP2, and MICB with the same
lentiviral vectors mentioned above. An effective transduction
was observed (Figure 1E), and around 30% reduction in the
endogenous ULBP3 expression was noticed in the presence
of miR-J1-3p, also in this cell line (Figures 1F and 1G).Inc.
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Figure 2. Investigating the Mechanisms of miR-J1-3p-Mediated Reduction of ULBP3 Expression
(A) Percentages (indicated in the figure) of GFP-positive 293T cells transduced with the indicated miRNAs.
(B) FACS analysis of all detectable NKG2D ligands’ expression by 293T cells, following transduction with miR-J1-3p (black open histogram), or with the control
miR (gray open histogram). The filled gray histogram represents the staining of the second mAb only. Figure shows one representative experiment out of three
performed.
(C) Quantification of ULBP3 expression in 293T cells transduced with miR-J1-3p relative to 293T cells transduced with the control miR. Statistically significant
differences are indicated (*p < 0.005, by one-tailed t test). Error bars (SD) are derived from the result of three independent experiments.
(D) QPCR analysis of the mRNA levels of ULBP3 found in 293T cells transduced with miR-J1-3p, or with miR-J1-5p as indicated. Specific ULBP3 Taq-man
primers were used. Error bars (SD) are derived from triplicates. Results are representative of three independent experiments.
(E) Subtle changes in ULBP3 expression leads to a significant reduction in NK-mediated killing. 293T cells were transduced with various shRNAs directed against
ULBP3 (three in total), or with a control shRNA (used as reference shRNA, indicated in the figure as 0% reduction). The reduction in the MFI of ULBP3 expression
was calculated relative to the MFI levels of ULBP3 expression in cells tranduced with the control scramble sequence. The various 293T cells, expressing the
various shRNAs, were then labeled and incubated for 5 hr with bulk NK cells at an effector:target (E:T) ratio of 6:1. Shown are mean values ± SD. Statistically
significant differences are indicated (*p < 0.005, by one-tailed t test). Error bars (SD) are derived from triplicates.
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Polyomaviruses miRNA Target ULBP3Investigating the Mechanisms of miR-J1-3p-Mediated
ULBP3 Downregulation
We have previously demonstrated that the cellular and the
viral miRNAs that were found to modulate MICB expression
are probably operating through inhibition of translation (Stern-
Ginossar et al., 2007, 2008; Nachmani et al., 2009; Nachmani
et al., 2010). To investigate the mechanisms by which miR-
J1-3p mediates the reduction of ULBP3 expression and to
reinforce our above observations, we transduced another cell
line, 293T, with the viral miRNAs mentioned above (Figure 2A).
The 293T cell line endogenously expresses ULBP3, MICA, and
ULBP2 (Figure 2B). As can be seen in Figure 2B, and in agree-
ment with the above results (Figure 1), around 30% reduction
in ULBP3 expression was observed also in 293T cells expressing
miR-J1-3p, relative to the control miR, miR-J1-5p (Figures 2B
and 2C). Because the downregulation of ULBP3 expression
was not associated with a decrease in the mRNA levels of
ULBP3, as detected by quantitative real-time PCR (QPCR)
analysis (Figure 2D), we concluded that miR-J1-3p probably
reduces ULBP3 levels through inhibition of translation.Cell HoThe miRNA-mediated reduction of ULBP3 (Figures 1 and 2)
and of MICB (Nachmani et al., 2009, 2010; Stern-Ginossar
et al., 2007, 2008) is moderate. Nevertheless, we demonstrated
before (Nachmani et al., 2009, 2010; Stern-Ginossar et al.,
2007, 2008) that such moderate reduction in the stress-induced
ligand MICB is functional. To quantify the extent of the ULBP3
downregulation that is needed to obtain a significant reduction
in NK cytotoxicity, we transduced 293T cells with various
shRNAs directed against ULBP3 (three in total, Figure 2E), or
with a control shRNA construct which includes a scramble
sequence. We obtained several 293T clones expressing various
levels of ULBP3 (the expression levels of all other NKG2D
ligands remained unchanged [data not shown]), and we
calculated the percentages of ULBP3 reduction relative to
the expression of the ULBP3 on 293T cells transduced with
the scrambled shRNA (designated as 0% reduction in Fig-
ure 2E). Interestingly, we observed that even subtle changes
in ULBP3 expression (as low as 15% reduction, Figure 2E)
were sufficient to cause a substantial reduction in NK
cytotoxicity.st & Microbe 9, 93–102, February 17, 2011 ª2011 Elsevier Inc. 95
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Figure 3. The miRNA-Mediated ULBP3 Downregulation Resulted in Reduced NKG2D-Mediated Killing
(A) Percentages (indicated in the figure) of GFP-positive U87 cells transduced with miR-J1-3p and miR-J1-5p.
(B) FACS analysis of all detectable NKG2D ligands expressed by U87 cells, transduced with lentiviral vectors encoding either miR-J1-3p (black open histogram),
or the control miRNA miR-J1-5p (gray open histogram). The filled gray histogram represents the staining of the second mAb only.
(C) Quantification of ULBP3 expression in U87 cells, transduced with miR-J1-3p relative to U87 cells transduced with the control miR. Shown are mean values ±
SD. Statistically significant differences are indicated (*p < 0.005, by one-tailed t test). Error bars (SD) are derived from the result of three independent experiments.
(D) Reduced NKG2D-mediated killing of U87 cells overexpressing miR-J1-3p. Bulk NK cells were preincubated either with anti-NKG2D mAb (empty circle or
square) or with isotype-match control mAb (filled circle or square). Labeled U87 cells expressing either miR-J1-3p (circle) or miR-J1-5p (square) were then added
and incubated for 5 hr at the indicated effector:target (E:T) ratios. Shown are mean values ± SD. Statistically significant differences are indicated (*p < 0.005, by
one-tailed t test). Error bars (SD) are derived from triplicates. Figure shows one representative experiment out of three performed.
Cell Host & Microbe
Polyomaviruses miRNA Target ULBP3The Viral miRNA-Mediated Reduction of ULBP3
Expression Leads to Reduced NKG2D-Dependent
Killing
We next aimed to study the functional outcome of the reduced
ULBP3 expression mediated by miR-J1-3p. For that purpose
we transduced another cell line, the U87 cell line (a glioblastoma
cell line, representing the cells that are naturally infected by
the JC virus), with the lentiviral vectors encoding the different
miRNAs mentioned above (Figure 3A). In agreement with the
above results, around 30% reduction in the expression of
ULBP3, but not of ULBP2 or MICA, was observed when
miR-J1-3p was overexpressed in these cells, whereas the
control miR had no effect (Figures 3B and 3C).
Next, we performed NK cytotoxicity assays against the trans-
duced U87 cells. As can be seen in Figure 3D, and in agreement
with the reduction of ULBP3 expressionmediated bymiR-J1-3p,
a significant decrease in the U87 killing was observed whenmiR-
J1-3p, but not the control miR, was present in the cells. The
miRNA-mediated reduction of NK cytotoxicity resulted from
reduced NKG2D recognition, as killing of all cells was equivalent
when the NKG2D interactions were blocked (Figure 3D).96 Cell Host & Microbe 9, 93–102, February 17, 2011 ª2011 ElsevierMiR-J1-3p Directly Binds to the 30UTR of ULBP3
Our next aimwas to determine whether themiR-J1-3p-mediated
ULBP3 downregulation is direct and whether it is executed
through its binding to 30UTR of ULBP3. Since the 30UTR
sequence of the ULBP3 mRNA was unknown, we cloned
ULBP3 (NM_024518.1) together with its unknown UTR from
a cDNA library made of U87 cells and determined its sequence
(Figure 4A). We next used the online RNAhybrid program
(http://bibiserv.techfak.unibielefeld.de/rnahybrid/submission.
html) to scan for potential binding sites of miR-J1-3p and identi-
fied such a site, which contains a full seed match for miR-J1-3p,
located between nucleotides 267 and 290 (Figure 4B). In
contrast, and in agreement with the above observations, no
seed-containing sites were identified for the miRNAs derived
from the 5p arms of both JCV and BKV. To test whether
miR-J1-3p indeed targets this specific site, we preformed dual
luciferase reporter assays. We generated two firefly luciferase
constructs, one containing the wild-type 30UTR of ULBP3, and
a second one containing the 30UTR in which we mutated the
seed region of the predicted miR-J1-3p binding site (Fig-
ure 4C).These constructs were transiently transfected into cellsInc.
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Figure 4. The JCV and BKVmiRNAs Directly
Bind to the 30UTR of ULBP3
(A) The sequence of the 30UTR of the ULBP3 gene
obtained from a cDNA library made from the U87
cell line.
(B) A schematic representation of the 30UTR of
ULBP3 and the predicted binding site for BKV-
miR-B1-3p/JCV-miR-J1-3p miRNAs.
(C) Alignment of miR-J1-3p and the mutated
30UTR of ULBP3 (double point mutations in the
predicted seed region are marked in bold and
are underlined).
(D) The figure demonstrates relative luciferase
activity after transfection of the indicated reporter
plasmids: wild-type (WT), or mutant ULBP3
30UTR, into MDA-MB-231 cells expressing either
miR-J1-3p (gray) or the control miR-J1-5p (white).
Firefly luciferase activity was normalized to Renilla
luciferase activity and then normalized to the
average activity of the control reporter. Shown
are mean values ± SD. Statistically significant
differences are indicated (*p < 0.001) by one-tailed
t test). Error bars (SD) are derived from triplicates.
Figure shows one representative experiment out of
three performed.
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Polyomaviruses miRNA Target ULBP3that had been transduced with miR-J1-3p, or with a control
miRNA. As can be seen in Figure 4D, a decrease in luciferase
activity was observed only in cells expressing miR-J1-3p,
while the mutations in the 30UTR of ULBP3 abolished this
observed effect. Thus, both JCV and BKV express an identical
miRNA that specifically targets the 30UTR of ULBP3, reduces
its expression, and consequently diminishes the NKG2D-
mediated killing.
MiR-J1-3p Reduces ULBP3 Expression during Infection
to Escape NKG2D Recognition
Our next aim was to demonstrate that the miRNA-mediated
reduction of ULBP3 expression plays a significant role during
viral infection. For an unknown reason, despite numerous
attempts, the use of various virus stocks (purchased from
ATCC) and various cell lines, we were unable to infect cells
with BKV. However, because JCV and BKV express the same
relevant miRNA, we continued our analysis with the JCV only.
All cell lines (RKO and BJAB, Figure 1; 293T, Figure 2; and
U87, Figure 3) that we used here to demonstrate the miR-
J1-3p effect express ULBP3 on the cell surface prior to the
miRNA transduction. Although the expression of ULBP family
members could be detected under normal conditions on healthy
cells (Eagle et al., 2009), it might be possible that the cells which
are naturally infected in vivo with JCV do not express ULBP3
before the infection. To investigate whether JCV infection will
affect ULBP3 expression, we infected U87 cells with 512 hemag-
glutination units (HAUs) of JCV and verified that the cells were
indeed infected by western blot analysis to detect the presence
of the JCV large T antigen in the infected cells (Figure 5A). Next
we performed QPCR analysis to determine the mRNA levels of
the NKG2D ligands (ULBP3, ULBP2, and MICA), expressed by
U87 cells, before and after JCV infection. As can be seen in Fig-
ure 5B, significant increase in the mRNA levels of ULBP3 and
MICA, but not of ULBP2, was observed in the infected cells
compared to uninfected cells.Cell HoWe next aimed to determine whether this elevation in mRNA
levels of MICA and ULBP3will result in increased protein expres-
sion and whether miR-J1-3p could prevent this elevation. Again,
U87 cells were infected with 512 HAU of JCV, and since the JCV
miRNAs (both the 3p* and the 5p) were shown to be expressed
around 72 hr postinfection (Seo et al., 2008), we started moni-
toring ULBP3 expression at that time. No significant change in
the levels of MICA, ULBP2, or ULBP3 expression was observed
at this time point, 72 hr postinfection (data not shown), despite
the induction of mRNA for MICA and ULBP3 (Figure 5B). In
contrast, 6 days following the infection we noticed a reduction
in ULBP3 expression in the infected cells (Figure 5C), which
correlated with the increased expression of miR-J1-3p (around
50-fold above control, Figure 5D). The expression of ULBP2 or
MICA remained unchanged (Figure 5C), indicating that the
observed effect is specific. The expression of ULBP3 remained
low in the following days until U87 cells lost viability. To further
examine the mechanism leading to ULBP3 downregulation
following JCV infection, we performed western blot analysis to
detect the ULBP3 protein levels before and after the infection.
As could be seen in Figure 5E and despite the elevation in the
ULBP3 mRNA levels following infection (Figure 5B), around
70% reduction in the ULBP3 protein level was observed
following the infection. Finally, we have also determined that
the reduction in ULBP3 expression during infection resulted in
a parallel reduction in NK cytotoxicity (Figure 5F).
Inhibition of miR-J1-3p Activity during Infection
Restored ULBP3 Expression and Enhanced
NK Killing of the JCV-Infected Cells
Our final aimwas to block themiR-J1-3p function and to demon-
strate directly that this miRNA indeed facilitates the downregula-
tion of ULBP3 during infection. We therefore generated an
antiviral miRNA sponge directed against miR-J1-3p. Sponges
directed against a particular miRNA contain multiple adjacent
binding sites for the miRNA of interest and thus function asst & Microbe 9, 93–102, February 17, 2011 ª2011 Elsevier Inc. 97
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Figure 5. The JCV miRNA miR-J1-3p Reduced ULBP3 Expression during JCV Infection
(A) Western blot analysis of T-antigen (T-ag) protein expression in uninfected cells (left lane), or in JCV-infected U87 cells (right lane). Results are representative of
two independent experiments.
(B) QPCR analysis of the mRNA level of ULBP3, ULBP2, and MICA following JCV infection of U87 cells. Specific Taq-man primers were used. Statistically
significant differences are indicated (*p < 0.02 by one-tailed t test). Error bars (SD) are derived from triplicates. Results are representative of three independent
experiments.
(C) FACS analysis of ULBP3, ULBP2, and MICA expression in U87 cells infected with JCV (black open histogram) and on uninfected cells (gray open histogram),
6 days following infection. The filled gray histogram represents the staining of the second mAb only.
(D) QPCR analysis of viral miR-J1-3p miRNA expression, 6 days following JCV infection of U87 cells. U87 cells transduced with lentiviral vector encoding
miR-J1-3p were used as positive control. Statistically significant differences are indicated (*p < 0.02 by one-tailed t test). Error bars (SD) are derived from trip-
licates. Results are representative of three independent experiments.
(E) Western blot analysis of ULBP3 protein levels in uninfected U87 cells (left lane), or in JCV-infected cells (right lane). Lower bands in each lane represent the
Lamin A protein control. These Lamin controls also serve as controls for (A). Results are representative of two independent experiments.
(F) U87 cells infected with JC virus exhibit reduced NKG2D-mediated NK killing. Bulk NK cells were preincubated either with anti-NKG2D mAb or with isotype
control. Infected (gray bars) or uninfected (white bars) U87 cells were then added and incubated for 5 hr at the indicated effector:target (E:T) ratios. Shown are
mean values ± SD. Statistically significant differences are indicated (*p < 0.03, by one-tailed t test). Error bars (SD) are derived from triplicates. Figure shows one
representative experiment out of three performed.
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Polyomaviruses miRNA Target ULBP3‘‘decoy transcripts’’ that sequester the miRNA from targeting its
original target (Ebert et al., 2007). The antiviral miRNA sponge
was cloned in the 30UTR of GFP reporter cassette, and the
sponge was transduced into U87 cells. This strategy enabled
us not only to monitor for the transduction efficiency, but also
to detect the sponge activity during infection, as the sponge
absorption of the relevant miRNA will lead to a reduction in the
GFP intensity. Uninfected or JCV-infected U87 cells were trans-
duced with the sponge directed against miR-J1-3p or with
a control sponge (the transduction of the sponge directed
against miR-J1-3p into U87 cells did not alter ULBP3 expression,
or affected the NK-mediated cytotoxicity of uninfected cells [see
Figure S1 available online]). The GFP and ULBP3 expression
levels were determined as infection progressed. As shown in98 Cell Host & Microbe 9, 93–102, February 17, 2011 ª2011 ElsevierFigures 6A and 6B, the infected cells transducedwith the sponge
directed against miR-J1-3p indeed showed a very prominent
decrease in the GFP intensity as compared either to U87 cells
transduced with a control sponge or to uninfected cells express-
ing miR-J1-3p sponge. This indicated that the JCV miRNA was
absorbed during infection. Importantly, the sequestration of the
JCV miRNA by the anti-miR-J1-3p sponge resulted in increased
expression of ULBP3, whereas no change was observed either
in ULBP2 or in MICA expression (Figure 6C).
In general, and as also observed throughout the paper, the
miRNA effect is moderate (Baek et al., 2008). We also demon-
strated here that the moderate ULBP3 downregulation mediated
by miR-J1-3p was noticed on the entire cell population (see
Figures 1–3 and 5) and that even 15% reduction in ULBP3Inc.
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Figure 6. Inhibition of miR-J1-3p Activity during Infection Restored ULBP3 Expression and Enhanced NK Killing of the JCV-Infected Cells
(A) FACS analysis of theGFP intensity in U87 cells transduced either with lentiviral vector encoding for sponge directed against miR-J1-3p (black open histogram),
or with a control sponge (EBV-miR-BART1-5p, gray open histogram).
(B) Relative GFP intensity of JCV-infected and uninfected cells transduced with sponge for miR-J1-3p (gray column), or with the miR BART1-5p sponge (white
column). Shown aremean values ± SD. Statistically significant differences are indicated (*p < 0.008, by one-tailed t test). Error bars (SD) are derived from the result
of three independent experiments.
(C) FACS analysis of ULBP3, ULBP2, and MICA expression by infected U87 cells transduced by lentiviral vector encoding sponge against miR-J1-3p (gray open
histogram),or control sponge (EBV-miR-BART1-5p, black open histogram). The filled gray histogram represents the staining of the second mAb only.
(D) Quantification of ULBP3 downregulation (infected and transduced with sponge against miR-J1-3p compared to control sponge) and upregulation (infected
compared to uninfected). Statistically significant differences are indicated (*p < 0.03, by one-tailed t test). Error bars (SD) are derived from three independent
experiments.
(E) Western blot analysis for the expression of ULBP3 in infected cells transduced with the indicated anti-miRNA sponge (x axis), 6 days following infection. The
Lamin A protein was used as loading control. Results are representative of two independent experiments.
(F) Bulk NK cells were preincubated either with anti-NKG2DmAb or with isotype control mAb. Infected U87 cells transduced with sponge against JCV-miR-J1-3p
(gray bar) or with control sponge (white bar) were then added and incubated for 5 hr at the indicated effector:target (E:T) ratios. Shown are mean values ± SD.
Statistically significant differences are indicated (*p < 0.02, by one-tailed t test). Error bars (SD) are derived from triplicates. Figure show one representative exper-
iment out of three performed. (See also Figure S1.)
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(Figure 2). Nevertheless, to make sure that the moderate
effect observed during infection is indeed significant, we
repeated the infections and the sponge experiments several
times. Figure 6D summarizes the results of the downregulation
of ULBP3 expression mediated by miR-J1-3p and the sponge-
mediated upregulation of ULBP3, observed during infection.
Interestingly, around 20% reduction of ULBP3 expression (as
measured by MFI intensity) was observed during infection, and
this downregulation was almost completely reversed by the
anti-miR-J1-3p sponge activity (Figure 6D), indicating that the
observed moderate effect is reproducible and significant.
Because we observed a 70% downregulation of ULBP3 expres-
sion in western blot analysis, following infection (Figure 5E) and
to strengthen our observations we have also assayed theCell HomiR-J1-3p sponge effect on ULPB3 expression by using
western blot analysis. For that purpose and to make this exper-
iment more biologically relevant, we generated another sponge
which is directed against miR-J1-5p. U87 cells were infected
as indicated above, and 72 hr postinfection the cells were trans-
duced with a control irrelevant miR-BART1 sponge, with sponge
directed against miR-J1-5p and with the miR-J1-3p sponge, or
with no sponge. Importantly, around 40% elevation in the
ULBP3 expression was observed only with the miR-J1-3p
sponge (Figure 6E), indicating that indeed miR-J1-3p functions
during JCV infection to reduce ULBP3 expression. Finally, we
demonstrated that the anti-miR-J1-3p sponge-mediated
upregulation of ULBP3 had functional implications, as it resulted
in increased NKG2D-mediated recognition and killing of the
infected cells (Figure 6F).st & Microbe 9, 93–102, February 17, 2011 ª2011 Elsevier Inc. 99
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Polyomaviruses miRNA Target ULBP3All together, we show that by using identical miRNAs, JCV and
BKV downregulte the stress-induced ligand ULBP3 to escape
the NKG2D-mediated elimination.
DISCUSSION
In this report we describe an immune evasion mechanism of
human polyoma viruses. We also uncover a cellular gene which
is targeted by the miRNAs of human polyoma viruses and
demonstrate that a viral miRNA is able to target a stress-induced
ligand of the ULBP family.
We have undertaken an unbiased practical approach and not
a computational based strategy to determinewhether indeed the
JCV and BKV miRNAs target the stress-induced ligands of
NKG2D. This approach was proven to be successful, not only
because the computer algorithms that are presently available
to predict miRNA targets are highly inaccurate, but also because
the 30UTR of ULBP3 was unknown and thus would have been
missed by using a computational approach.
The miRNAs of JC, BK, and of simian virus 40 (SV40) are
derived from homologous pre-miRNA hairpins, in which both
arms are processed into mature miRNAs that downregulate
the viral Tag (Seo et al., 2008; Sullivan et al., 2005). Although
the miRNA derived from the 3p arm is considered as the star
miRNA, in the sense that it is less abundant than the miRNA
derived from the 5p arm, this star miRNAwas functional in down-
regulating the viral Tag (Seo et al., 2008). In agreement with this
observation, we demonstrate here that miR-J1-3p (the star
miRNA of BKV and JCV) is functional also in downregulating
a host gene, ULBP3. Moreover, we found that miR-J1-3p,
despite being a star miRNA, is expressed in quite significant
levels above background, and that such expression levels
were sufficient for the ULBP3 downregulation.
Because all polyoma viruses miRNAs, so far discovered, are
located antisense to the viral Tag, researchers speculated that
the only function of these miRNAs might be to target this protein
(Cullen, 2009; Seo et al., 2008; Umbach and Cullen, 2009).
However, as both cellular and viral miRNAs are estimated to
target around 300 genes (Skalsky and Cullen, 2010), this
assumption seemed to us unlikely. Our hypothesis was that pol-
yoma viruses miRNAs might target additional genes that would
be essential for the life cycle of these viruses. This hypothesis
was further supported by the observations that the miRNAs of
some herpes viruses are also found antisense to a particular viral
gene; however, they could still downregulate the expression of
other genes (Boss et al., 2009). One notable example with this
regard is the HCMV miR-UL112, which is located antisense to
the viral UL114 gene and downregulates not only this protein
(Stern-Ginossar et al., 2009) but also MICB (Stern-Ginossar
et al., 2007) and the viral gene IE72 (Grey et al., 2007). A fasci-
nating question to which the answer is currently unknown is
how these miRNAs that are placed antisense to the viral genes
acquire the ability to also target cellular genes.
Interestingly, the targeting of the Tag by the SV40miRNAs was
shown to affect CTL responses against peptides derived from
the Tag (Sullivan et al., 2005). Whether the Tag downregulation
by the miRNAs of JCV and BKV would also affect CTL activity
is still unknown. However, it is logical to assume that targeting
of the Tag by BKV and JCV miRNA will result in escape from100 Cell Host & Microbe 9, 93–102, February 17, 2011 ª2011 ElsevieCTL attack. Thus, by usingmiRNAs, JCV and BKVwould escape
the detection of both the innate and adaptive immune systems.
Furthermore, since NKG2D is expressed by many immune cells
including innate NK cells and various T cells subsets, we suggest
that by using a single miRNA, the human polyoma viruses may
escape the NKG2D-mediated detection and elimination of both
the innate and adaptive immune systems.
As mentioned above, MICB is the only known NKG2D ligand
targeted by the miRNAs derived from the herpes viruses
HCMV, KSHV, and EBV (Nachmani et al., 2009; Stern-Ginossar
et al., 2007). In contrast, as we show here, the miRNAs of BKV
and JCV target ULBP3 only. Thus, we wondered why the
miRNAs of polyoma and herpes viruses target different stress-
induced ligands. An analogous question might be why the
NKG2D receptor has so many different ligands (eight in total
[Champsaur and Lanier, 2010]). We think that the answer to
both questions is that these different stress-induced ligands
and the opposing viral mechanisms were coevolved due to
a host-pathogen ‘‘arm race.’’ Thus, the upregulation of the
different stress ligands might be related either to the different
cell types which are infected by polyoma and herpes viruses,
or alternatively, to the life cycle of the different viruses. The
viruses, on the other hand, developed specific miRNA-based
mechanisms to interfere with the expression of the specific
stress ligands induced by each of the viruses.
The stress-induced ligands of human and mouse are different,
and ULBP3 (or other human stress-induced ligands) does not
exist in the mouse. Thus, the miRNAs-based mechanisms
used by both polyoma and herpes viruses to escape immune
detection are one of the nicest examples for how human viruses
that coevolved with humans for millions of years target stress
ligands which are unique to humans. Because the stress ligands
are different in human and mice, it is almost impossible to find
a satisfactory in vivo model to study whether the miRNA-medi-
ated reduction of ULBP3 would be indeed significant in vivo
during the course of authentic infection. We think, however,
that our results strongly suggest that, indeed, this is the case.
The miRNAs effect is, in general, moderate (Baek et al., 2008),
and the ULBP3 reduction during infection was moderate as well.
Importantly, however, suchmoderate downregulation resulted in
decreased killing of the infected cells. Furthermore, the reduc-
tion in the ULBP3 protein levels following infection is actually
greater than the ULBP3 reduction observed on the cell surface.
An intrinsic property of ULBP3 and of other NKG2D ligands such
asMICB orMICA is their swift induction upon stress (Champsaur
and Lanier, 2010), and indeed we demonstrate that the mRNA
levels of ULBP3 and MICA are induced during JCV infection
and that, in contrast, the ULBP3 protein levels are reduced.
Thus, the miR-J1-3p viral miRNA not only reduces the expres-
sion of ULBP3 which is already present on the cell surface but
also prevents the translation of the newly synthesized ULBP3
mRNA, following infection. Indeed, western blot analysis for
the expression of ULBP3 protein following infection reveled
around 70% reduction in ULBP3 expression, whereas the
miRNA-mediated surface downregulation of ULBP3 following
infection was limited to around 20% only. Furthermore, the
anti-miR-J1-3p sponge activity resulted in around 20% elevation
of ULBP3 expression on the cell surface and 40% elevation of
ULBP3 protein expression.r Inc.
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following infection, no elevations in the levels of MICA and
ULBP3 were observed on the surface of infected cells at any
time point following the infection. On the contrary, we demon-
strate here that the miRNA of JCV downregulates ULBP3
expression, at 6 days postinfection. These results suggests
that other possible mechanisms of posttranscriptional control
including inhibition of translation, rapid degradation of newly
translated proteins, or sequestration inside the cell might also
operate in the infected cells, to prevent the expression of the
stress-induced ligands, similar to protein-based mechanisms
used by HCMV and KSHV (Dunn et al., 2003).
It was shown recently that human polyoma viruses proteins,
RNA, and DNA are found in many human tumors (Moens and
Johannessen, 2008), suggesting that these viruses might
contribute to tumorigenesis processes. Although this area of
research is still highly speculative, our finding may suggest that
viral components might be essential not only for tumor transfor-
mation, but also for tumor escape from the NKG2D-mediated
elimination. The understanding that ULBP3 plays a dominant
role during JCV and BKV infection may lead to the development
of antiviral drugs aiming either at antagonizing the miRNA effects
or upregulating the expression of ULBP3 in polyoma virus-in-
fected cells and tumors.
EXPERIMENTAL PROCEDURES
Lentiviral Constructs, Production, and Transduction
RNA artificial hairpins that function as orthologs of pre-miRNA hairpins were
generated by using the pTER vector (van de Wetering et al., 2003). Two
complementary specific oligonucleotides (Table S1) were annealed, phos-
phorylated using T4 polynucleotide kinase, and inserted into the pTER vector
as was previously described (van deWetering et al., 2003). The artificial hairpin
and H1 RNA polymerase III promoter were then excised from the vector and
cloned into the lentiviral vector SIN18-pRLL-hEFIap-E-GFP-WRPE. The vector
also contains GFP cassette, thus allowing the simultaneous expression of both
the reporter GFP and the relevant miRNA. Sponge constructs were generated
by annealing the oligonucleotides, phosphorylating them using T4 polynucle-
otide kinase, and inserting them into the pcDNA3 vector (Invitrogen). The
sponges were excised and cloned into the lentiviral vector SIN18-pRLL-hE-
FIap EGFP-WRPE (Xu et al., 2001), downstream to the GFP cassette. Each
sponge consists of six adjacent binding sites for the relevant viral miRNA,
separated by a 4 nt spacer. The sequences of the sponge’s binding site are
as follows: sponge anti-miR-J1-3p (50 to 30), GACTCTGGACTACATCAAGCA;
sponge anti-miR-bart1-5p (control), CACAGCACGTCAGAACACTAAGA. Len-
tiviral vectors were produced by transient three-plasmid transfection protocol.
The pMDG envelope expression cassette (3.5 mg), the gag-pol packaging
construct (6.5 mg), and the relevant vector construct (10 mg) were transfected
into 293T cells using the LT1 transfection reagent (Mirus Bio LLC, Madison,
WI). Two days after transfection, the supernatants containing viruses were
collected and filtered. These viruses where then used to transduce cells in
the presence of polybrene (5 mg/ml). ShRNAs for ULBP3 were obtained from
Sigma-Aldrich in the pLKO.1 plasmid. Lentiviral vectors were produced by
using the three-plasmid transient transfection method as described above.
Transduced 293T cells were grown in medium supplemented with 1ug/ml
puromycin. The ShRNA sequences directed against ULBP3 were as follows:
clone #1, GCCAGGTGGATCAGAAGAATT; clone #2, CTTCTTCAAGATGG
TCTCAAT; clone #3, CGCTCACTCTCTCTGGTATAA.
Cytotoxicity Assays and NK Cell Preparation
The cytotoxic activity of NK cells against various targets was assessed in 5 hr
35S release assays as described (Mandelboim et al., 1996). The final concen-
tration of the blocking antibodies was 2.5 mg/ml. NK cells were isolated from
peripheral blood using the Human NK Cell Isolation Kit and the autoMACSCell Hosinstrument (Miltenyi Biotec) according to the manufacturer’s instructions.
The NK purity was 100% as determined by FACS analysis. The spontaneous
release in all assays was always less than 15% of the total release and is
subtracted from the calculation of the percentages of lysis. Percentages of
killing were calculated as follows: (CPM sample  CPM spontaneous)/(CPM
total  CPM spontaneous)*100.
Cells, Viruses, and Antibodies
The BJAB, U87, 293T, RKO, and MDA–MB-321 cell lines were used. Anti-
MICA, anti-MICB, anti-ULBP1-3, and anti-NKG2D antibodies were all
purchased from R&D Systems (Minneapolis). ULBP3 antibody for western
blotting was purchased from R&D (catalog MAB15171). The anti-SV40 Tag
antibody (pab416) that cross-reacts with JCV Tag was purchased from Abcam
(catalog ab16879) and was used for western blotting. The anti-CD99 (12E7)
was used as an isotype control. Anti-CD56 antibody (Becton Dickinson) and
anti-CD3 (biolegend) were used to determine NK purity. JC (MAD-4, catalog
VR-1583) and BK virus (Cat.VR-837) were purchased from the ATCC. JC virus
was propagated in COS-7 for 7 days, at 37C. Cells were grown in minimum
Eagle’s medium supplemented with 2% fetal bovine serum. Seven days later,
the infected cells together with supernatant were freeze-thawed six times, and
virus titers were determined by hemagglutination assay as described (Liu and
Atwood, 2001). Briefly, human red blood cells of type O donors were added to
2-fold dilution series of virus (preincubated with 0.25% of sodium deoxycho-
late) in a U-shaped microtiter plate. Virus titer was determined according to
the highest dilution in which hemagglutination was still visible. The human
glioblastoma cell line U87 was infected with 512 HAUs of JC virus for 1 hr at
37C in reduced (2%) sera.
Real-Time PCR of miR-J1-3p
Total RNA was isolated by using the Tri-Reagent (Sigma) and treated with
RNase-free DNase-Turbo (Ambion). The treated total RNA (1 mg) was polyade-
nylated by poly(A) polymerase (PAP) at 37C for 1 hr in a 20 ml reaction mixture
using the Poly(A) Tailing Kit (Ambion). After phenol-chloroform extraction and
ethanol precipitation, the RNA was dissolved in diethylpyrocarbonate (DEPC)-
treated water. It then was reverse transcribed with mMLV Reverse Transcrip-
tase (Invitrogen) and with 0.5 mg of poly(T) adaptor (30 rapid amplification of
complementary DNA ends [RACE] adaptor using the FirstChoice RLM-RACE
kit; Ambion) according to the manufacturer’s instructions. Quantitative PCR
was used to measure miRNA expression was as follows: 2 ml of cDNA was
mixed with 200 mM of both the forward and reverse primers in a final volume
of 10 ml and mixed with 10 ml of 23 DyNAmo SYBR Green qPCR (Finnzymes).
5S rRNA and U6 snRNA were used as the endogenous reference genes for
PCR quantification. The reverse primer was a 30 adaptor primer (30RACE outer
primer in the First Choice RLM-RACE kit), and the forward primer was de-
signed based on the entire miRNA sequence. For miR-J1-3p, 50-TGCTTGAT
CCATGTCCAGAGTC-30. QPCR for the expression of ULBP3, MICA, and
ULBP2 mRNA was conducted with specific commercial Taq man primers
(Applied Biosystems).
DNA Constructs and Luciferase Assay
For the firefly luciferase vector, we used the pGL3 control vector (Promega).
The 30UTR of ULBP3 was amplified by PCR from U87 cell line cDNA library
and inserted into XbaI site immediately downstream to a stop codon. The
inserts and their proper orientation were confirmed by sequencing. The
primers used to amplify ULBP3 30UTR were as follows: forward, 50-TCTCTAG
AGGCTTAGGGACTTCCTGA-30; reverse, 5-TGGCTGCTGGGATCATGATCTA
GAGA-30. For the generation of the mutated ULBP3-30UTR plasmid, we
included a double point mutation in the seed region of binding site using
an additional set of primers: forward, 5-AAGCAGGAGTTCCCGCCTTAGCA
AG-30; and reverse, 50-CTTGCTAAGGCGGGAACTCCTGCTT-30.
MDA-MB-321 cells were plated in 24-well plates were transfected with
100 ng of a Firefly luciferase reporter vector and 5 ng of the control Renilla lucif-
erase pRL-CMV (Promega) using the LT1 transfection reagent (Mirus), at a final
volume of 0.5 ml. Firefly and Renilla luciferase activities were measured
consecutively with the Dual-Luciferase Assay System (Promega) 48 hr
following transfection. Firefly luciferase activity was normalized to Renilla
luciferase activity and then normalized to the average activity of the control
reporter.t & Microbe 9, 93–102, February 17, 2011 ª2011 Elsevier Inc. 101
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Cells were counted and lysed in buffer containing 0.6% SDS and 10 mM Tris
(pH 7.4). Proteins concentration in each sample was determined by Bradford
method. Equal volumes of samples containing equal protein concentrations
were then run on 12.5% Tris-HCl gels, then transferred onto nitrocellulose
and incubated for 1 hour with 5% milk. Membranes were incubated overnight
with primary Ab; for the blotting of ULBP3, anti-ULBP3 mAb in 3%BSA (1:500)
was used. For the blotting of JC T-antigen, anti-Tag mAb in 3%BSA (1:50) was
used. Anti-mouse-HRP (Jackson Laboratory) was used as secondary
antibody.
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